Task: Answer the MCQ question.
Question: Which drug exhibits a 0.403% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CN1CCN(c2ccc(S(=O)(=O)N3CCCCC3)cc2NC(=O)/C=C/c2ccc(OC(F)F)cc2)CC1
b Cc1cc(C(=O)OCC(=O)Nc2nnc(C(C)C)s2)c2ccccc2n1
Answer: b. Cc1cc(C(=O)OCC(=O)Nc2nnc(C(C)C)s2)c2ccccc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C(=O)OCC(=O)Nc2nnc(C(C)C)s2)c2ccccc2n1
Cc1cc(C(=O)OCC(=O)Nc2nnc(C(C)C)s2)c2ccccc2n1
[2-oxo-2-[(5-propan-2-yl-1,3,4-thiadiazol-2-yl)amino]ethyl] 2-methylquinoline-4-carboxylate